Literature DB >> 26617898

Relationship between serologic response and clinical symptoms in children with enterovirus 71-infected hand-foot-mouth disease.

Jun Shen1, Chao Zhao2, Ping Cao1, Peng Shi3, Lingfeng Cao4, Qirong Zhu1.   

Abstract

This study aimed to explore the correlation between clinical symptoms, including rash and fever, and serum antibody reaction to enterovirus 71 (EV71) infection in children hospitalized due to hand-foot-mouth disease (HFMD). From May 2014 to July 2014, a total of 547 children hospitalized due to HFMD in Children's Hospital of Fudan University were enrolled retrospectively. RNA levels of EV71 and CA16 in fecal, serum, and cerebrospinal fluid specimens were measured using quantitative real-time RT-PCR, and EV71-IgM antibody in the serum was detected using immune colloidal gold assays. Of the 547 fecal specimens, 296 were EV71 RNA positive, 109 were CA16 RNA positive, and 8 were positive for both EV71 RNA and CA16 RNA. The total positive rate for either EV71 or CA16 in feces was 72.58% (397/547). Additionally, 544 serum specimens were collected, and 409 were EV71-IgM positive (75.18%). The duration of rash and fever was found to be correlated to the positive rate of serum EV71-IgM, and the positive rate of serum EV71-IgM plus EV71 RNA in feces. The positive rates of serum EV71-IgM and serum EV71-IgM plus EV71 RNA in fecal collected at day 3 of fever were 79.7% and 52.8%, respectively. In conclusion, EV71 and CA16 were found to be the major pathogens responsible for the epidemics of HFMD in children during May to July 2014 in Shanghai, China. There is a close relationship between the positive rate of serum EV71-IgM and the duration of fever and rash.

Entities:  

Keywords:  Hand-foot-mouth disease; children; enterovirus 71; fever; rash; serum antibody

Mesh:

Substances:

Year:  2015        PMID: 26617898      PMCID: PMC4637714     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  21 in total

1.  Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackieviruses A10.

Authors:  Qin Yang; Jinya Ding; Junhao Cao; Qianchuan Huang; Chun Hong; Bin Yang
Journal:  J Med Virol       Date:  2015-03-09       Impact factor: 2.327

2.  Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis.

Authors:  Feihai Xu; Qiang Yan; Hua Wang; Jianjun Niu; Liang Li; Fengcai Zhu; Shuizhen He; Shiyin Zhang; Zuxing Weng; Tong Cheng; Yijun Cai; Delei He; Yixin Chen; Shengxiang Ge; Anthony E T Yeo; Jun Zhang; Mun-Hon Ng; Ningshao Xia
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

3.  Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: a randomized controlled trial.

Authors:  Chia-Yu Chi; Truong Huu Khanh; Le Phan Kim Thoa; Fan-Chen Tseng; Shih-Min Wang; Le Quoc Thinh; Chia-Chun Lin; Han-Chieh Wu; Jen-Ren Wang; Nguyen Thanh Hung; Tang Chi Thuong; Chung-Ming Chang; Ih-Jen Su; Ching-Chuan Liu
Journal:  Crit Care Med       Date:  2013-07       Impact factor: 7.598

4.  Severe enterovirus type 71 nervous system infections in children in the Shanghai region of China: clinical manifestations and implications for prevention and care.

Authors:  Qingli Zhang; Noni E MacDonald; Jennifer C Smith; Kang Cai; Huiju Yu; Huajun Li; Chuene Lei
Journal:  Pediatr Infect Dis J       Date:  2014-05       Impact factor: 2.129

5.  Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Feng-Cai Zhu; Fan-Yue Meng; Jing-Xin Li; Xiu-Ling Li; Qun-Ying Mao; Hong Tao; Yun-Tao Zhang; Xin Yao; Kai Chu; Qing-Hua Chen; Yue-Mei Hu; Xing Wu; Pei Liu; Lin-Yang Zhu; Fan Gao; Hui Jin; Yi-Juan Chen; Yu-Ying Dong; Yong-Chun Liang; Nian-Min Shi; Heng-Ming Ge; Lin Liu; Sheng-Gen Chen; Xing Ai; Zhen-Yu Zhang; Yu-Guo Ji; Feng-Ji Luo; Xiao-Qin Chen; Ya Zhang; Li-Wen Zhu; Zheng-Lun Liang; Xin-Liang Shen
Journal:  Lancet       Date:  2013-05-29       Impact factor: 79.321

Review 6.  Clinical features, diagnosis, and management of enterovirus 71.

Authors:  Mong How Ooi; See Chang Wong; Penny Lewthwaite; Mary Jane Cardosa; Tom Solomon
Journal:  Lancet Neurol       Date:  2010-11       Impact factor: 44.182

7.  Epidemiological and etiological characteristics of hand, foot, and mouth disease in Henan, China, 2008-2013.

Authors:  Xueyong Huang; Haiyan Wei; Shuyu Wu; Yanhua Du; Licheng Liu; Jia Su; Yuling Xu; Haifeng Wang; Xingle Li; Yanxia Wang; Guohua Liu; Weijun Chen; John David Klena; Bianli Xu
Journal:  Sci Rep       Date:  2015-03-10       Impact factor: 4.379

8.  Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China.

Authors:  Wei Li; Lina Yi; Juan Su; Jing Lu; Hanri Zeng; Dawei Guan; Cong Ma; Wanly Zhang; Hong Xiao; Hui Li; Yonghui Zhang; Jinyan Lin; Changwen Ke
Journal:  BMC Infect Dis       Date:  2013-07-15       Impact factor: 3.090

9.  Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia.

Authors:  Sokkosal Chea; Yi-Bing Cheng; Kulkanya Chokephaibulkit; Tawee Chotpitayasunondh; H Rogier van Doorn; Zen Hafy; Surinda Kawichai; Ching-Chuan Liu; Nguyen Tran Nam; Mong How Ooi; Marcel Wolbers; Mei Zeng
Journal:  Emerg Infect Dis       Date:  2015-01       Impact factor: 6.883

10.  Enterovirus genotypes causing hand foot and mouth disease in Shanghai, China: a molecular epidemiological analysis.

Authors:  Menghua Xu; Liyun Su; Lingfeng Cao; Huaqing Zhong; Niuniu Dong; Jin Xu
Journal:  BMC Infect Dis       Date:  2013-10-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.